Active ingredients: nabiximols
What it is used for
Sativex is indicated as treatment, for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.
How to take it
The way to take this medicine is: Oromucosal.
- Store at 2 to 8 degrees Celsius
- Replace the cover firmly after use
- Store Upright
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Yellow/brown solution in a brown, plastic-coated glass spray container
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is
Pregnant or planning a pregnancy?
For the active ingredient nabiximols
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems